The accuracy of pulse oximetry readings on individuals with darker skin tones has been questioned by researchers. The FDA addressed the issue at a meeting last year, citing real-world studies showing the potential for misdiagnosis or delays in treatment due to poor readings.
Neil Friedman, founder and chief operating officer of Bodimetrics, sat down with MobiHealthNews to discuss the company's...
